期刊文献+

甲磺酸伊马替尼对K562细胞bcr/abl、SHIP-2基因表达的影响及意义

The influence and significance of Gleevic on the expression of bcr/abl and SHIP2 gene in K562 cell line
下载PDF
导出
摘要 目的研究甲磺酸伊马替尼对K562细胞bcr/abl、SHIP2的表达影响及意义。方法采用定量PCR方法检测甲磺酸伊马替尼干预K562细胞后bcr/abl、SHIP2基因表达变化。采用MTT及Western blot方法分别检测细胞增殖与AKT磷酸化水平的变化。结果随着甲磺酸伊马替尼浓度增加及作用时间的延长bcr/abl基因的表达下降(P<0.01),SHIP2的表达增加(P<0.01)。Akt磷酸化水平降低,细胞增殖能力降低。结论甲磺酸伊马替尼能下调bcr/abl基因的表达;SHIP2表达可能受bcr/abl基因的调节,并可能通过调节PI3K/AKT途径影响细胞的增殖。 Objective To investigate the influence and significance of Gleevic on the expression of bcr/abl and SHIP2 gene in K562 cell line.Methods The quantitative PCR was used to detect the expression of bcr/abl and SHIP2 gene in K562 cells after treated with Gleevic,and MTT and Western Blot were used respectively to detect the proliferation and phosphor-Akt levels of K562 cells after treated with Gleevic.Results With the increase of concentration of Gleevic and the prolangation of action time,the expression of bcr/abl gene was decreased in K562 cells,however,the SHIP2 gene expression was increased.The cell proliferation decreased and the levels of phosphor-Akt was decreased.Conclusion Gleevic can down-regulate the expression of bcr/abl gene.The expression of SHIP2 may be regulated by bcr/abl gene,which may affec cell proliferation by way of PI3K/AKT.
出处 《河北医药》 CAS 2010年第7期771-773,共3页 Hebei Medical Journal
基金 国家自然科学基金资助项目(编号:30240011)
关键词 白血病 髓系 慢性 BCR-ABL阳性 甲磺酸伊马替尼 基因表达 leukemia medullary system chronic BCR-ABL positive Gleevic the expression of gene
  • 相关文献

参考文献2

二级参考文献15

  • 1罗建民,刘泽林,郝洪岭,王福旭,董作仁,大野竜三.急性白血病细胞SHIP基因的突变分析[J].中华血液学杂志,2004,25(7):385-388. 被引量:13
  • 2张苏江,李建勇,施静艺,史占中,顾柏炜,白雪涛,朱勇梅,沈志祥.急性髓系白血病患者PDGFRβ和SHIP基因突变及其单核苷酸多态性研究[J].中华血液学杂志,2006,27(6):383-385. 被引量:11
  • 3Kisseleva MV, Cao L, Majerus PW. Phosphoinositide-specific inositol phlyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death. J Biol Chem 2002; 277(8): 6266-6272.
  • 4Liu QR, Sasaki T, Kozieradzki I, Wakeham A, Itie A, Dumont D J, Penninger JM. SHIP is negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999; 13(7): 786-791.
  • 5Luo JM, Yoshida H, Komura S, Ohishi IV, Pan L, Shigeno K, Hanamura I, Miura K, Iida S, Ueda R, Naoe T, Akao Y, Ohno R, Ohnishi K. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 2003; 17(1): 1-8.
  • 6Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian ceils, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33(3): 401-406.
  • 7Xu Q, Simpson SE, SciaUa TJ, Bagg A, Carroll M. Survival of acute myeloid leukemia cells requries PI3 kinase activition. Blood 2003; 102(3): 972-980.
  • 8Gloire G, Charlier E, Rahmouni S, Volanti C,Chariot A, Emeux C, Piette J. Restoration of SHIP-1 activity in human leuke- mic cells modifies NF-kB activation pathway and cellular survival upon oxidative stress. Oncogene 2006; 25(40): 5485- 5494.
  • 9Hirsch E, Costa C, Ciraolo E. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J Endocrinol 2007; 194(2): 243-256.
  • 10Poter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6(2): 99-104.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部